Sulindac and Docetaxel in Treating Women With Metastatic or Recurrent Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: docetaxel|DRUG: sulindac
Sponsor: Fox Chase Cancer Center
Collaborators: National Cancer Institute (NCI)